Effect of feedback letters to physicians and pharmacists on the appropriate use of medication in the treatment of asthma

Journal of Asthma

Volumn 45, Issue 3, 2008, Pages 227-231

  Blais, Régis ^a   Laurier, Claudine ^a   Paré, Michèle ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Appropriate use; Asthma; Feedback; Medication; Pharmacists; Physicians

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG;

ARTICLE; ASTHMA; CANADA; CONSUMER HEALTH INFORMATION; DRUG INFORMATION; DRUG USE; FOLLOW UP; HUMAN; MEDICAL ASSESSMENT; PATIENT COMPLIANCE; PHARMACIST; PHARMACIST ATTITUDE; PHYSICIAN; POSTAL MAIL; PRACTICE GUIDELINE; PRESCRIPTION; SAMPLE SIZE; STATISTICAL SIGNIFICANCE;

ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CORRESPONDENCE AS TOPIC; DISEASE MANAGEMENT; DRUG UTILIZATION; HUMANS; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; QUEBEC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 42249101529     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900701883774     Document Type: Article

References (25)

1. Beasley R. The burden of asthma with specific reference to the United States. J. Allergy Clin. Immunol 2002; 109:S482-S489.
2. Masoli M, Fabian D, Holt SS, Beasley R. Global Burden of asthma. Global initiative on asthma; 2004: http://www.ginasthma.com/Reports.asp?l1=2&l2=2
3. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2006. Available from: http://www.ginasthma.org
4. Chen Y, Johansen H, Thillaiampalam S, Sambell C. L'asthme. Rapports sur la santé 2005; 16(2):45-48 (Statistiques Canada 82-003).
5. Boulet LP, Bai TR, Becker A, Bérubé D, Beveridge R, Bowie DM, et al. What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J 2001; 8 (suppl A):5A-27A.
6. Blais R, Grégoire JP, Rouleau R, Cartier A, Bouchard J, Boulet LP. Comité de revue de l'utilisation des médicaments. Ambulatory use of inhaled beta(2)-agonists for the treatment of asthma in Quebec: a population-based utilization review. Chest 2001; 119:1316-1321.
7. Conseil du médicament. Revue de l'utilisation des agonistes β2 inhalés et des antagonistes des récepteurs des leucotriènes employés dans le traitement de l'asthme. Sainte-Foy, Québec; 2003: http://www.cdm.gouv.qc.ca/site/index.php?fr publications etudes
8. Labrecque M, Laurier C, Champagne F, Kennedy W, Paré M, Cartier A. Effect of age on the conformity rate to short-acting beta-agonist use criteria in asthma. J Asthma 2003; 40:829-835.
9. Laumann JM, Bjornson DC. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology. Ann Pharmacother 1998; 32:1290-1294.
10. Hartert TV, Togias A, Melle BG, Mitchel EF, Snowden MS, Griffin MR. Underutilization of controller and rescur medications among older adults with asthma requiring hospital care. JAGS 2002; 48:651-657.
11. Anis AH, Lynd LD, Wang XH, Spinelli JJ, Fitzgerald M, Bai T, Pare P. Double Trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001; 164:625-631.
12. Shireman TI, Heaton PC, Gay WE, Cluxton RJ, Moomaw CJ. Relationships between asthma drug therapy patterns and health care utilization. Annals of Pharmacother 2002; 36:557-564.
13. Gilberg K, Laouri M, Wade S, Isonaka S. Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression and CHF. J. Manag Care Pharmacy 2003; 9:232-237.
14. WHO Adherence to long-term therapies-Evidence for action. Geneva: World Health Organisation 2003.
15. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L. Changing provider behaviour: An overview of systematic reviews of interventions. Med Care 2001; 39(suppl 2):2-45.
16. Pearson SA, Ross-Degnan D, Payson A, Soumerai SB. Changing medication use in managed care: a critical review of the available evidence. Am J Managed Care 2003; 9:715-731.
17. Balas EA, Boren SA, Brown GD, Ewigman BG, Mitchell JA, Perkoff GT. Effect of physician profiling on utilization. Meta analysis of randomized clinical trial. J Gen Intern Med 1996; 11:584-590.
18. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes, Cochrane Database of Systematic Review 2006; (2):CD000259.
19. Buntinx F, Knottnerus JA, Crebolder HFJM, Essed GGM, Schouten H, Seegers T. Does feedback improve the quality of cervical smears? A randomized controlled trial. Br J Gen Pract1993; 43:194-198.
20. Coleman CG, Reddy P, Laster-Bradley NM, Dorval S. Effect of practitioner education on adherence to asthma treatment guidelines. Ann Pharmacother 2003; 37:956-961.
21. Kattan M, Crain EF, Steinbach S, Visness CM, Walter M, Stout JW, et al. A randomized clinical trial of clinician feedback to improve quality of care for inner-city children with asthma. Pediatrics 2006; 117:1095-1103.
22. Sondergaard J, Andersen M, Vach K, Kragstrup J , Macclure M, Gram LF. Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed non impact: a randomized controlled trial. Eur J Clin Pharmacol 2002; 58:127-132.
23. Lagerlov P, Loeb M, Andrew M, Hjortdahl P. Improving doctor's prescribing behaviour through reflection on guidelines and prescription feedback: a randomized controlled study. Qual Health Care 2000; 159-165.
24. Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P, on behalf of the Canadian Asthma Consensus Group. Canadian Asthma Consensus Report, 1999. CMAJ 1999; 161(11 suppl): S1-S62.
25. Collins TM, Mott DA, BigelowWE, Zimmerman DR. A Controlled letter intervention to change prescribing behavior: Results of a dual-targeted approach. Health Services Research 1997; 32:471-489.